Deal: Global law firm Ashurst has advised National Australia Bank, UBS and Westpac Institutional Bank as arrangers and joint lead managers of an offer of non-cumulative, convertible, transferable, redeemable, subordinated, perpetual unsecured notes by Challenger Limited to raise $250 million.

Value: $250 million.

Area: Capital markets.

Key players: The Ashurst team was led by partner Sarah Dulhunty, assisted by senior associate Simon Vose and lawyer Kyle McLachlan.

Deal significance:  The offer includes an institutional offer, a broker firm offer, a reinvestment offer and a securityholder offer. 

Under the reinvestment offer, eligible holders of Challenger Capital Notes 1 (CCN1) are able to reinvest​ in Challenger Capital Notes 3. 

In addition to the offer and reinvestment offer, eligible CCN1 holders may choose to have their CCN1 repurchased for their face value of $100 each, payable in cash.

VIEW ALL

Challenger intends to use the proceeds of the offer to fund the regulatory capital requirements of Challenger Life Company Limited, the registered life company of the Challenger Group, and to refinance the Challenger Capital Notes 1 (issued in 2014) through the reinvestment offer and repurchase invitation.